Mystery of hepatitis e Virus: Recent advances in its diagnosis and management

International Journal of Hepatology

Volumn 2015, Issue , 2015, Pages

  Ahmed, Aftab ^a   Ali, Ijlal Akbar ^a   Ghazal, Hira ^b   Fazili, Javid ^c   Nusrat, Salman ^c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS VACCINE; PEGINTERFERON; RIBAVIRIN;

ACUTE HEPATITIS; ARTICLE; CHRONIC HEPATITIS; CLINICAL FEATURE; DEVELOPING COUNTRY; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); PREGNANCY; PRIORITY JOURNAL; TAXONOMIC RANK; VACCINATION; VIROLOGY; VIRUS TRANSMISSION;

EID: 84928526172     PISSN: 20903448     EISSN: 20903456     Source Type: Journal    
DOI: 10.1155/2015/872431     Document Type: Article

References (51)

1. S. Fujiwara, Y. Yokokawa, K. Morino, K. Hayasaka, M. Kawabata, and T. Shimizu, Chronic hepatitis E: a review of the literature, Journal of Viral Hepatitis, vol. 21, no. 2, pp. 78-89, 2014.
2. C. Féray, J.-M. Pawlotsky, A.-M. Roque-Afonso, D. Samuel, and D. Dhumeaux, Should we screen blood products for hepatitis e virus RNA? The Lancet, vol. 383, no. 9913, p. 218, 2014.
3. N. Kamar, H. R. Dalton, F. Abravanel, and J. Izopet, Hepatitis E virus infection, Clinical Microbiology Reviews, vol. 27, no. 1, pp. 116-138, 2014.
4. J. E. Arends,V.Ghisetti,W. Irving et al., Hepatitis E: an emerging infection in high income countries, Journal of Clinical Virology, vol. 59, no. 2, pp. 81-88, 2014.
5. N. Kamar, R. Bendall, F. Legrand-Abravanel et al., Hepatitis E, The Lancet, vol. 379, pp. 2477-2488, 2012.
6. S. Mirazo, N. Ramos, V. Mainardi, S. Gerona, and J. Arbiza, Transmission, diagnosis, and management of hepatitis E: an update, Journal ofHepaticMedicine: Evidence and Research, vol. 6, pp. 45-59, 2014.
7. M. T. Pérez-Gracia, B. Suay, and M. L. Mateos-Lindemann, Hepatitis E: an emerging disease, Infection, Genetics and Evolution, vol. 22, pp. 40-59, 2014.
8. S. Pischke and H. Wedemeyer, Hepatitis E virus infection: multiple faces of an underestimated problem, Journal of Hepatology, vol. 58, no. 5, pp. 1045-1046, 2013.
9. J.-M. Echevarría, Light and darkness: prevalence of hepatitis E virus infection among the general population, Scientifica, vol. 2014, Article ID481016, 14 pages, 2014.
10. N. Kamar, R. Bendall, F. Legrand-Abravanel et al., Hepatitis E, The Lancet, vol. 379, no. 9835, pp. 2477-2488, 2012.
11. H. R. Dalton, J. G. Hunter, and R. Bendall, Autochthonous hepatitis e in developed countries and HEV/HIV coinfection, Seminars in Liver Disease, vol. 33, no. 1, pp. 50-61, 2013.
12. P. Colson, P. Borentain, B. Queyriaux et al., Pig liver sausage as a source of hepatitis e virus transmission to humans, The Journal of Infectious Diseases, vol. 202, no. 6, pp. 825-834, 2010.
13. H. R. Dalton, Hepatitis E: the new kid on the block or an old friend? Transfusion Medicine and Hemotherapy, vol. 41, no. 1, pp. 6-9, 2014.
14. P. C. Y. Woo, S. K. P. Lau, J. L. L. Teng et al., New hepatitis E virus genotype in camels, the Middle East, Emerging Infectious Diseases, vol. 20, no. 6, pp. 1044-1048, 2014.
15. C. Alvarado-Esquivel, L. F. Sanchez-Anguiano, and J. Hernandez-Tinoco, Seroepidemiology of hepatitis E virus infection in general population in rural durango, Mexico, Hepatitis Monthly, vol. 14, no. 6, Article IDe16876, 2014.
16. S. Kumar, S. Subhadra, B. Singh, and B. K. Panda, Hepatitis E virus: the current scenario, International Journal of Infectious Diseases, vol. 17, no. 4, pp. e228-e233, 2013.
17. T. M. Pavri, D. A. Herbst, and K. R. Reddy, Chronic hepatitis E virus infection: challenges in diagnosis and recognition in the United States, Journal of Clinical Gastroenterology, vol. 49, no. 1, pp. 86-88, 2014.
18. F. Montella, G. Reza, F. di Sora, P. Pezotti, and O. Recchia, Association between hepatitis E virus and HIV infection in homosexual men, The Lancet, vol. 344, no. 8934, p. 1433, 1994.
19. B. A. I. Payne, M. Medhi, S. Ijaz et al., Hepatitis E virus seroprevalence among men who have sex with men, United Kingdom, Emerging Infectious Diseases, vol. 19, no. 2, pp. 333- 335, 2013.
20. Y. Geng, H. Zhang, W. Huang et al., Persistent hepatitis E virus genotype 4 infection in a child with acute lymphoblastic leukemia, Hepatitis Monthly, vol. 14, no. 1, Article ID e15618, 2014.
21. J. H. Hoofnagle, K. E. Nelson, and R. H. Purcell, Current concept hepatitis E,The New England Journal of Medicine, vol. 367, pp. 1237-1244, 2012.
22. C. L. Crossan, K. J. Simpson, D. G. Craig et al., Hepatitis E virus in patients with acute severe liver injury, World Journal of Hepatology, vol. 6, no. 6, pp. 426-434, 2014.
23. S. Haim-Boukobza, A. Coilly, M. Sebagh et al., Hepatitis E infection in patients with severe acute alcoholic hepatitis, Liver International, 2014.
24. I. Al-Shukri, E. Davidson, A. Tan et al., Rash and arthralgia caused by hepatitis E, The Lancet, vol. 382, no. 9907, p. 1856, 2013.
25. J. Price, An update on hepatitis B, D, and E viruses, Topics in Antiviral Medicine, vol. 21, no. 5, pp. 157-163, 2013.
26. D. B. Smith and P. Simmonds, Hepatitis E virus and fulminant hepatitis-a virus or host-specific pathology? Liver International, 2014.
27. J. H. Hoofnagle, K. E. Nelson, and R. H. Purcell, Hepatitis E, The New England Journal of Medicine, vol. 367, no. 13, pp. 1237- 1244, 2012.
28. R. Aggarwal Jr., Epidemiologic concerns and advances in knowledge on hepatitis E, Gastroenterology & Hepatology, vol. 9, no. 3, pp. 173-175, 2013.
29. I.Masood, A. Rafiq, and Z.Majid, Hepatitis E presenting with thrombocytopaenia, Tropical Doctor, vol. 44, no. 4, pp. 219- 220, 2014.
30. S.-J. Huang, X.-H. Liu, J. Zhang, and M.-H. Ng, Protective immunity against HEV, Current Opinion in Virology, vol. 5, pp. 1-6, 2014.
31. T. Comont, D. Bonnet, N. Sigur, A. Gerdelat, F. Legrand- Abravanel, N. Kamar et al., Acute hepatitis E infection associated with Guillain-Barré syndrome in an immunocompetent patient, La Revue de Medecine Interne, vol. 35, no. 5, pp. 333- 336, 2014.
32. X. Wu, K. Liu, and H. L. Zhang, Guillain-Barré syndrome and encephalitis/encephalopathy associated with acute severe hepatitis E infection, Neurological Sciences, 2014.
33. A. Belbezier, A. Deroux, F. Sarrot-Reynauld, S. Larrat, and L. Bouillet, Myasthenia gravis associated with acute hepatitis E infection in immunocompetent woman, Emerging Infectious Diseases, vol. 20, no. 5, pp. 908-910, 2014.
34. N. Kamar, J. Selves, J.-M. Mansuy et al., Hepatitis E virus and chronic hepatitis in organ-transplant recipients, The New England Journal of Medicine, vol. 358, no. 8, pp. 811-817, 2008.
35. X. Zhou, R. A. de Man, R. J. de Knegt, H. J. Metselaar, M. P. Peppelenbosch, and Q. Pan, Epidemiology and management of chronic hepatitis E infection in solid organ transplantation: a comprehensive literature review, Reviews in Medical Virology, vol. 23, no. 5, pp. 295-304, 2013.
36. H.R.Dalton, R. P. Bendall, F. E. Keane, R. S. Tedder, and S. Ijaz, Persistent carriage of hepatitis E virus in patients with HIV infection, The New England Journal of Medicine, vol. 361, no. 10, pp. 1025-1027, 2009.
37. Z. Abbas and R. Afzal, Hepatitis E: when to treat and how to treat, AntiviralTherapy, vol. 19, no. 2, pp. 125-131, 2014.
38. M. T. Giordani, P. Fabris, E. Brunetti, S. Goblirsch, and L. Romano, Hepatitis E and lymphocytic leukemia inman, Italy, Emerging InfectiousDiseases, vol. 19,no. 12,pp. 2054-2056, 2013.
39. Y. Wang, H. J. Metselaar, M. P. Peppelenbosch, and Q. Pan, Chronic hepatitis E in solid-organ transplantation: the key implications of immunosuppressants, CurrentOpinion in Infectious Diseases, vol. 27, no. 4, pp. 303-308, 2014.
40. N.Kamar and J. Izopet, Does chronic hepatitis E virus infection exist in immunocompetent patients? Hepatology, vol. 60, no. 1, p. 427, 2014.
41. J. J. van Eijk, R. GMadden, A. A. van der Eijk et al., Neuralgic amyotrophy and hepatitis E virus infection, Neurology, vol. 82, no. 6, pp. 498-503, 2014.
42. A. Deroux, J. P. Brion, L. Hyerle et al., Association between hepatitis E and neurological disorders: two case studies and literature review, Journal of Clinical Virology, vol. 60, no. 1, pp. 60-62, 2014.
43. M. A. de Vries, J. P. A. Samijn, R. de Man, and J. M. M. Boots, Hepatitis E-associated encephalopathy in a renal transplant recipient, BMJ Case Reports, 2014.
44. D. J. Seo, H. Tahk, K. B. Lee et al., Detecting hepatitis E virus with a reverse transcription polymerase chain reaction enzyme-linked immunosorbent assay, Food and Environmental Virology, vol. 4, no. 1, pp. 14-20, 2012.
45. T. Vollmer, C. Knabbe, and J. Dreier, Comparison of real-time PCR and antigen assays for detection of hepatitis e virus in blood donors, Journal of Clinical Microbiology, vol. 52, no. 6, pp. 2150-2156, 2014.
46. N. Kamar, F. Abravanel, J. Selves et al., Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-e virus infection after organ transplantation, Transplantation, vol. 89, no. 3, pp. 353-360, 2010.
47. A. Robbins, D. Lambert, F. Ehrhard et al., Severe acute hepatitis E in an HIV infected patient: successful treatmentwith ribavirin, Journal of Clinical Virology, vol. 60, no. 4, pp. 422- 423, 2014.
48. N. Kamar, L. Rostaing, F. Abravanel et al., Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection, Gastroenterology, vol. 139, no. 5, pp. 1612-1618, 2010.
49. V. Mallet, E. Nicand, P. Sultanik et al., Brief communication: case reports of ribavirin treatment for chronic hepatitis E, Annals of Internal Medicine, vol. 153, no. 2, pp. 85-89, 2010.
50. H.Wedemeyer, S. Pischke, and M. P.Manns, Pathogenesis and treatment of hepatitis E virus infection, Gastroenterology, vol. 142, no. 6, pp. 1388.e1-1397.e1, 2012.
51. F.-C. Zhu, J. Zhang, X.-F. Zhang et al., Efficacy and safety of a recombinant hepatitis e vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial, The Lancet, vol. 376, no. 9744, pp. 895-902, 2010.